Crossmark

L-carnitine improves polycystic ovary syndrome by increasing CYP11A1, estrogen receptor, and decreasing XNIP and VEGF expression

Published Online: 2026-03-16

Published Print: 2026-05

Authors

Lotfishokouh, Marzieh

Foroutan, Tahereh
Funding

Funding for this research was provided by:

Iran National Science Foundation (4049568)
License Information

Text and Data Mining valid from 2026-03-16

Version of Record valid from 2026-03-16
More Information

Article History

Received: 25 December 2025

Accepted: 9 February 2026

First Online: 16 March 2026

Declarations

:

: The authors declare no competing interests.

Document is current